Good morning :)
$
₹
BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp Common stock

BGLC

NASDAQ
Asset Logo

BioNexus Gene Lab Corp Common stock

BGLC

NASDAQ
$1.152.94% (-0.03)
$
₹
$1.152.94% (-0.03)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Basic Materials

Specialty Chemicals

Micro Cap

With a market cap of $3.5M the stock is ranked 6038

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.55
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.26
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-82.36%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Sherwin-Williams Co
SHW
Sherwin-Williams Co
P/E Ratio
31.06
31.06
1Y Return
1.83%
1.83%
Buy Reco %
51.72
51.72
Ecolab Inc
ECL
Ecolab Inc
P/E Ratio
38.72
38.72
1Y Return
4.91%
4.91%
Buy Reco %
83.33
83.33
PPG Industries Inc
PPG
PPG Industries Inc
P/E Ratio
15.89
15.89
1Y Return
7.66%
7.66%
Buy Reco %
52.00
52.00
International Flavors & Fragrances Inc
IFF
International Flavors & Fragrances Inc
P/E Ratio
93.21
93.21
1Y Return
43.15%
43.15%
Buy Reco %
70.00
70.00
RPM International Inc
RPM
RPM International Inc
P/E Ratio
18.25
18.25
1Y Return
12.09%
12.09%
Buy Reco %
87.5
87.5
Compare with Peers

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

2.5
-0.7
0.4
-1
0
-0.5
0
-0.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue2.381.972.632.522.132.262.540.480.020.07
Net Income-0.100.19-1.34-0.34-0.62-0.61-0.70-1.03-0.54-0.28
Net Profit Margin-4.35%10.08%-51.14%-13.80%-29.16%-27.26%-27.87%-214.17%-2379.71%-376.13%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
Basic MaterialsSpecialty Chemicals

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
BioNexus Gene Lab Corp Common stock -0.55-
Sherwin-Williams Co31.0620.362.08
Ecolab Inc38.727.572.44
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare BGLC with any stock or ETF
Compare BGLC with any stock or ETF
Comparing from
BGLC
SHW
ECL
Loading...

Frequently asked questions

  1. BioNexus Gene Lab Corp Common stock (BGLC) share price today is $1.15 as of October 27, 2026 at 1:28 AM IST. The stock touched a day high of $1.18 and a day low of $1.12.

  2. BioNexus Gene Lab Corp Common stock stock trades on NASDAQ under the ticker symbol BGLC.

  3. BioNexus Gene Lab Corp Common stock's market capitalization is $3.49M as of October 27, 2026 at 1:28 AM IST.

  4. BioNexus Gene Lab Corp Common stock's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. BioNexus Gene Lab Corp Common stock's price-to-book (P/B) ratio is 0.55 as of October 26, 2026.

  6. Yes, You can buy BioNexus Gene Lab Corp Common stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy BioNexus Gene Lab Corp Common stock shares in three steps: 1. Search BioNexus Gene Lab Corp Common stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since BioNexus Gene Lab Corp Common stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in BioNexus Gene Lab Corp Common stock (BGLC) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 8.658 shares at the current price of $1.15.

Loading...